Our Partners
Helmholtz Munich
A renowned German research center dedicated to discovering personalized medical solutions by studying the interactions between genetics, environment and lifestyle. Eximmium was founded in April 2021 in Munich as a Helmholtz spin-off. Shortly thereafter, we executed an exclusive licensing agreement that grants us the rights to develop and commercialize novel antibodies for advanced cancer therapeutics and diagnostic applications.
The Agency for Science, Technology & Research (A*STAR)
A*STAR is Singapore’s leading public research institution, driving innovation through advanced scientific research and industry collaboration. Eximmium maintains a laboratory on Singapore’s vibrant Biopolis hub and collaborates with A*STAR to advance development of antibody products and cell therapies.
LMU University Hospital
The hospital complex of the Ludwig Maximilian University of Munich (LMU) is one of the largest hospitals in Europe. Eximmium maintains close collaborations with the clinical research teams at this institution to accelerate the translation of innovations into clinical practice.
The Second Affiliated Hospital of Anhui
Located in Hefei, China, the Second Affiliated Hospital of Anhui Medical University is a large, modern teaching hospital that combines medical care, education, research, disease prevention, and rehabilitation. Highly active in clinical research, it conducts numerous investigator‑initiated and multicenter clinical trials across a wide range of specialties. Eximmium maintains close ties with the Department of Hematology and, together with the experts there, investigates the application of new targets for cell therapies.
Microcoat Biotechnologie GmbH
Microcoat is a biotechnology company based south of Munich, specializing in kit manufacturing, solid-phase coating, and diagnostic testing. Eximmium collaborates with Microcoat on the development of innovative diagnostic approaches based on cancer-derived extracellular vesicles. A central focus of this partnership is the standardization and quality control of these assays.
The Technical University of Munich
Consistently ranked among Europe’s leading technical universities, the Technical University of Munich (TUM) specializes in engineering, the natural sciences, medicine, and technology. Eximmium has established strong collaborations with various research groups to jointly explore innovative concepts for the development of improved cancer therapies.
